In a sequential crossover study of IVF conducted from 2002 to 2006, growth hormone (GH)
supplementation was assessed in poor-prognosis patients, categorized on the basis of past …

Background Patients undergoing in vitro fertilisation (IVF) receive various adjuvant therapies
in order to enhance success rates, but the true benefit is actively debated. Growth hormone …

Background Many studies have demonstrated the benefits of the addition of growth hormone
(GH) to the controlled ovarian stimulation protocol in vitro fertilization (IVF) cycles in poor …

Objective To evaluate the effectiveness of growth hormone (GH) supplementation in
improving the in vitro fertilization (IVF) outcomes of poor responders. Design Systematic …

Poor ovarian response (POR) often means low success rates after in vitro fertilisation (IVF).
We aim to study the impact of a low-dose growth hormone (GH) supplementation in …

Meta-analysis demonstrated a benefit for the use of the adjunct GH, with a reduction in the
duration of ovarian stimulation required for oocyte retrieval, the collection of a greater …

Growth hormone (GH) is a peptide hormone secreted mainly by the anterior part of the
pituitary gland and plays a critical role in cell growth, development, and metabolism …

Growth hormone (GH) has been shown to improve implantation and live birth rates in
women of> 40 years of age treated by in vitro fertilization (IVF). This effect was initially …

Research question Does the addition of human growth hormone (HGH) to an IVF cycle
improve the live birth rate in previously documented poor responders to FSH? Design …

Objective To study whether the effect of cotreatment with human biosynthetic GH improves
the outcome of poor IVF responders. Design A double-blind placebo-controlled study using …